Breaking Down The Latest Sensationalism About Ozempic | Solo
The Dr. Tyna Show
Empowering Health Choices
This chapter focuses on the speaker's approach to clinical cases and the importance of evidence-based information regarding GLP-1 medications. It emphasizes self-education, critical thinking, and family collaboration in combating misinformation and taking charge of one's health.
EP. 183: On this episode of the Dr. Tyna Show, I’m tackling three studies that have been making the rounds in the world of GLP1s. There’s been a lot of sensational talk lately claiming that GLP1s cause heart shrinkage, blindness, and erectile dysfunction—and I’m here to set the record straight. I’ll walk you through the studies, point out the limitations, and explain why many of these claims are being misrepresented on social media. Plus, I’ll even teach you how to bring in ChatGPT to help us break down the research. Join me as I clear up the confusion and discuss how many are again spreading misinformation about GLP1s.
Sponsored By:
- LMNT
- Get your free Sample Pack with any LMNT purchase at drinkLMNT.com/drtyna
- BIOptimizers
- Go to bioptimizers.com/drtyna and use code DRTYNA to save 10% and get a free gift with purchase
- Alitura
- Use Code DRTYNA20 for 20% off alituranaturals.com
- PaleoValley
- For 15% off go to http://paleovalley.com/drtyna
- Timeline Nutrition
- Go to timelinenutrition.com/DRTYNA and use code DRTYNA for 10% off
- Bite
- Go to trybite.com/DRTYNA or use code DRTYNA for 20% off
On This Episode We Cover:
- 00:00:00 - Introduction
- 00:01:00 - Ozempic and blindness
- 00:05:01 - Finding the limitations of studies
- 00:06:40 - Issues with Ozempic and blindness study
- 00:10:06 - Sensationalism around GLP1s
- 00:11:27 - GLP1s done right
- 00:14:51 - The discrediting of naturopathic doctors
- 00:18:42 - Erectile dysfunction study
- 00:24:02 - Ozempic & heart shrinking studies
- 00:28:48 - GLP1 dosing
- 00:30:27 - My GLP1 journey
Show Links:
Studies:
- Once-Weekly Semaglutide Doubles The Five-Year Risk Of Nonarteritic Anterior Ischemic Optic Neuropathy In A Danish Cohort Of 424,152 Persons With Type 2 Diabetes
- Semaglutide For Weight Loss May Increase Risk For Ed In Non-Diabetic Men
- Weight-Loss Drug Found To Shrink Heart Muscle In Mice, Human Cells
Further Listening:
Ozempic Uncovered Podcast Series:
- EP 106: Ozempic Done Right Part 1 | Solo Episode
- EP 107: Ozempic Done Right Part 2 | Solo Episode
- EP. 109: Ozempic Done Right Part 3 | Solo Episode
- Ep. 116: Berberine: NOT Nature's Ozempic | Quick & Dirty
- EP. 118: My GLP-1 Experience | Quick & Dirty
- EP. 129: Ozempic Done Right Part 4: Sustained Weight Loss | Solo Episode
- EP. 132: Ozempic Done Right Part 5: Osteoarthritis + GLP1 Agonists | Solo Episode
- EP. 136: Ozempic Does NOT Cause Muscle Loss | Solo Episode
Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.
The AI-powered Podcast Player
